A randomised controlled trial of lactobacillus in general practice to prevent post-antibiotic vulvovaginitis

ISRCTN ISRCTN24141277
DOI https://doi.org/10.1186/ISRCTN24141277
Secondary identifying numbers 2001/524 (number assigned by the Therapeutic Goods Administration in Australia)
Submission date
08/10/2002
Registration date
08/10/2002
Last edited
07/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jane Gunn
Scientific

Department of General Practice
200 Berkeley Street
Carlton
3053
Australia

Phone +61 (0)3 8344 4530
Email j.gunn@unimelb.edu.au

Study information

Study designRandomised controlled blinded 2 x 2 factorial design, with four intervention groups
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typePrevention
Scientific title
Study acronymPAV (post-antibiotic vulvovaginitis)
Study objectivesThis study aims to test in a randomised controlled trial whether oral and/or vaginal lactobacillus preparations can prevent post-antibiotic vulvovaginitis.
Ethics approval(s)The trial has received ethics approval from both the Royal Australian College of General Practitioners and the Royal Women's Hospital, Melbourne, Australia.
Health condition(s) or problem(s) studiedPost-antibiotic vulvovaginitis
InterventionFactorial design to test oral and vaginal lactobacillus species.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Lactobacillus
Primary outcome measureThe primary outcome is symptomatic vulvovaginal candidiasis, defined as:
1. Participants' report of symptoms (that is answer 'yes' to a question about symptoms of 'thrush' in survey 2: vaginal itch, irritation with or without a discharge)
2. Swab B culture positive for Candida species
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/07/2004
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants496
Key inclusion criteria1. Women aged between 18 and 50 years of age
2. Who are experiencing a non-genital infection
3. Rrequiring a short-course of oral antibiotics or have commenced this within the 48 hours preceding enrolment
4. English-speaking: able to speak, read and write in English sufficiently to provide informed consent and complete surveys
Key exclusion criteria1. Pregnancy
2. Experiencing any vaginal symptoms at recruitment
3. Unwilling or unable to provide two self-collected low vaginal swabs (at recruitment and on completion of trial)
4. Using or have used vaginal antifungal treatments in the past two weeks
5. Have taken antibiotics in the past month
6. Unwilling to stop taking other lactobacillus products during the trial
7. Immunocompromised, as there are rare reports in the literature of lactobacilli causing endocarditis and bacteraemia
Date of first enrolment01/07/2004
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • Australia

Study participating centre

Department of General Practice
Carlton
3053
Australia

Sponsor information

University of Melbourne (Australia)
University/education

-
Victoria
3010
Australia

Website http://www.unimelb.edu.au
ROR logo "ROR" https://ror.org/01ej9dk98

Funders

Funder type

Charity

Shepherd Foundation (Australia)

No information available

Royal Australian College of General Practitioners (Australia) (ref: 00/58)
Private sector organisation / Associations and societies (private and public)
Alternative name(s)
RACGP
Location
Australia
Department of Health and Aged Care (Australia) - scholarship for Dr Pirotta

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 28/03/2004 Yes No